Endocrinology and Metabolism Clinics of North America

Papers
(The median citation count of Endocrinology and Metabolism Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
An Update on the Epidemiology of Type 2 Diabetes187
The Epidemiology of Pituitary Adenomas148
Postmenopausal Osteoporosis127
Physiology of Calcium Homeostasis55
Lipid and Lipoprotein Metabolism51
Pituitary Tumors Centers of Excellence43
Diabetes Insipidus42
Diagnosis of Polycystic Ovary Syndrome40
Prevention of Microvascular Complications of Diabetes36
Screening for Diabetes and Prediabetes32
Pediatric Thyroid Cancer30
Diabetes and Osteoporosis29
Assessment of Cardiovascular Disease Risk28
Aggressive Pituitary Adenomas and Carcinomas28
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease28
New and Emerging Technologies in Type 1 Diabetes27
Update on the Genetics of Pituitary Tumors25
Anaplastic Thyroid Cancer25
Advances in the Imaging of Pituitary Tumors23
Management of Hypothalamic Obesity23
The Role of Dopamine Agonists in Pituitary Adenomas22
The Changing Nature of Mortality and Morbidity in Patients with Diabetes19
Advances in the Medical Treatment of Cushing Disease19
Characterizing Multimorbidity from Type 2 Diabetes18
Osteoporosis18
Inhaled Corticosteroids and Endocrine Effects in Childhood17
Endoscopic Surgery for Pituitary Tumors17
Acromegaly16
Cardiometabolic Risk in Polycystic Ovary Syndrome16
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes15
World Health Ozganization 2017 Classification of Pituitary Tumors15
Testosterone Replacement Therapy in Hypogonadal Men14
Polycystic Ovary Syndrome14
Ethnic Disparities in Diabetes14
Dyslipidemia in Diabetes14
Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism13
Hereditary Primary Hyperparathyroidism13
Nelson’s Syndrome13
Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays13
Updates on Osteoporosis in Men13
Safety of Statins and Nonstatins for Treatment of Dyslipidemia13
Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes13
A Novel Etiology of Hypophysitis12
Role of Bone Turnover Markers in Osteoporosis Therapy12
Nonclassic Congenital Adrenal Hyperplasia12
Diabetes and Osteoporosis12
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments11
Hypertriglyceridemia11
Obesity and Aging11
Testosterone, Diabetes Risk, and Diabetes Prevention in Men11
Genetics of Polycystic Ovary Syndrome11
Epidemiology of Male Hypogonadism11
Bone Health in Childhood Chronic Disease10
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis10
Prevention of Type 2 Diabetes10
Postmenopausal Hyperandrogenism10
Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention9
100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?9
Overview of Atypical Diabetes9
Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease9
Management of Women with Polycystic Ovary Syndrome During Pregnancy9
Management of Menopause Symptoms and Quality of Life during the Menopause Transition8
Evaluating the Impact of Acromegaly on Quality of Life8
Vitamin D–dependent Hypercalcemia8
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels8
Nonalcoholic Fatty Liver Disease8
Hypercalcemia of Malignancy7
Diabetes in Youth7
Pathophysiology of Hypercalcemia7
Sexual Dysfunctions in Women6
Advances in the Bone Health Assessment of Children6
Symptoms of Late-Onset Hypogonadism in Men6
The Inherited Hypercholesterolemias6
Disparities in Thyroid Care6
The Future of Thyroid Nodule Risk Stratification6
Drug-Related Hypercalcemia6
Glucocorticoid- and Transplantation-Induced Osteoporosis6
Rekindling Hope for Remission5
Tertiary and Postrenal Transplantation Hyperparathyroidism5
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone5
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period5
Root Cause for Metabolic Syndrome and Type 2 Diabetes5
Lipid Disorders and Metabolic-Associated Fatty Liver Disease5
Quality of Life in Primary Hyperparathyroidism5
Type 1 Diabetes and Aging5
Endocrine Sequelae in Childhood Cancer Survivors5
Hyperandrogenic Anovulation5
Male Reproduction and Aging5
Pathobiology of Metabolic-Associated Fatty Liver Disease5
Fertility Issues in Polycystic Ovarian Disease5
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents5
Treatment of Hypercalcemia of Malignancy5
Metabolic-Associated Fatty Liver Disease and Sarcopenia5
Testicular Dysfunction Among Cancer Survivors5
Minimally Invasive Techniques for the Management of Thyroid Nodules4
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism4
Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes4
Age-Associated Abnormalities of Water Homeostasis4
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome4
Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer4
Thyroid and Aging4
Fertility Considerations in Hypogonadal Men4
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia4
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease4
Hypercalcemia in Pregnancy4
Metabolic-Associated Fatty Liver Disease and Diabetes4
Disparities in Access to High-Volume Surgeons and Specialized Care4
Assessment of Skeletal Strength4
Lipoprotein Assessment in the twenty-first Century3
Rare Causes of Hypercalcemia3
Prevention of Diabetes Macrovascular Complications and Heart Failure3
Population-Level Approaches to Preventing Type 2 Diabetes Globally3
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes3
Racial and Ethnic Disparities in Access to and Outcomes of Infertility Treatment and Assisted Reproductive Technology in the United States3
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota3
Nontraditional Aspects of Sporadic Primary Hyperparathyroidism3
New and Emerging Therapies for Dyslipidemia3
Hormonal Injustice3
Management of Dyslipidemia in Endocrine Diseases3
Thyroid Dysfunction from Treatments for Solid Organ Cancers3
Endocrinology of Taste with Aging3
Diagnosis and Evaluation of Hypogonadism3
Islet Cell Therapy and Stem Cell Therapy for Type 1 Diabetes3
Patient-Reported Outcomes in Endoscopic Endonasal Skull Base Surgery3
Evaluating Patient-Reported Outcomes in Cushing’s Syndrome3
Growth Hormone and Aging3
Update on Approaches to Improve Delivery and Quality of Care for People with Diabetes3
Sporadic Primary Hyperparathyroidism3
Equity in Obesity Review3
Interventions Across the Translational Research Spectrum2
What Is a Honeymoon in Type 1, Can It Go into Remission?2
Risks of Testosterone for Postmenopausal Women2
Preconception Counseling and Care for Pregnant Women with Thyroid Disease2
Acute and Chronic Adverse Outcomes of Type 1 Diabetes2
LDL Cholesterol—How Low Can We Go?2
Novel Therapeutics for Advanced Differentiated Thyroid Cancer2
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?2
Use of Testosterone in Postmenopausal Women2
Pregnancy and Metabolic-Associated Fatty Liver Disease2
Emerging and Public Health Challenges Existing in Gestational Diabetes Mellitus and Diabetes in Pregnancy2
Less-Intensive Management Options for Low-Risk Thyroid Cancer2
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease2
Remission with an Intervention2
Endocrinology and Metabolism Clinics of North America2
Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men2
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence2
The Effects of Testosterone Treatment on Cardiovascular Health2
Anticipation of Precision Diabetes and Promise of Integrative Multi-Omics2
Updates on Osteoporosis2
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease2
Optimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men1
Thyroid Disorders: An Update1
2021 Updates on Osteoporosis Diagnosis and Therapy1
Type 1 Diabetes and Cardiovascular Health1
Use of Patient-Reported Outcomes for Assessing Diabetes Outcomes1
Racial and Ethnic Disparities in Metabolic Bone Disease1
Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes1
Testosterone Treatment and the Risk of Prostate Adverse Events1
Pituitary Endocrinology in 2020: An Update1
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge1
Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission?1
Updates on Osteoporosis1
Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio1
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents1
Remission in Ketosis-Prone Diabetes1
Global Health Disparities in Childhood Rickets1
Sex Hormones and Cardiovascular Disease in Relation to Menopause1
Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes1
Recognizing and Addressing Health Inequities in Endocrinology and Diabetes1
Diabetes Care in Humanitarian Settings1
Lean Metabolic-Associated Fatty Liver Disease1
Insights into the Genetic Underpinnings of Endocrine Traits from Large-Scale Genome-Wide Association Studies1
Management of Metabolic-Associated Fatty Liver Disease1
Emerging Technologies and Therapeutics for Type 1 Diabetes1
Diabetic Kidney Care Redefined with a New Way into Remission1
Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes1
Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults1
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes1
Primary Amenorrhea and Premature Ovarian Insufficiency1
The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men1
Quality of Life in Patients with Adrenal Insufficiency1
0.015941143035889